Hyperuricemia is an independent predictive factor for left ventricular diastolic dysfunction in patients with chronic

Leszek Gromadziński1, Beata Januszko-Giergielewicz2, Piotr Pruszczyk3

  • 1Department of Internal Diseases, Gastroenterology and Hepatology, University Clinical Hospital in Olsztyn, Poland.

Insights

High uric acid (UA) levels are linked to left ventricular (LV) diastolic dysfunction (DD) in chronic kidney disease (CKD) patients. Hyperuricemia independently predicts LV diastolic dysfunction in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Biochemistry

Background:

  • Elevated serum uric acid (UA) is a known poor prognostic factor in chronic heart failure and chronic kidney disease (CKD).
  • The relationship between hyperuricemia and left ventricular (LV) diastolic dysfunction (DD) in CKD patients requires further investigation.

Purpose of the Study:

  • To assess the impact of hyperuricemia on LV diastolic dysfunction (DD) in patients with chronic kidney disease (CKD).

Main Methods:

  • The study included 50 patients with CKD (stages 2-5).
  • Standard echocardiography and tissue Doppler imaging (TDI) were used to assess LV diastolic function (EmLV).
  • Serum UA and NT-proBNP levels were measured; patients were grouped based on EmLV values (<8 cm/s for DD, ≥8 cm/s for normal function).

Main Results:

  • Patients with LV diastolic dysfunction (DD+) had significantly higher serum UA levels compared to those with normal diastolic function (DD-) [6.7 vs 5.8 mg/dL].
  • Serum UA levels demonstrated good diagnostic performance for LV diastolic dysfunction (ROC AUC = 0.734, p=0.001), with a UA value > 6.0 mg/dL showing 76.9% sensitivity and 62.5% specificity.
  • Elevated UA level (> 6.0 mg/dL) was an independent predictor of LV diastolic dysfunction (OR = 14.3, p=0.006).

Conclusions:

  • Hyperuricemia is an independent predictive factor for left ventricular diastolic dysfunction in patients with chronic kidney disease.
  • Monitoring and managing uric acid levels may be crucial for preventing or treating diastolic dysfunction in CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
318
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
559
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.0K
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
119
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.2K